Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC):: A phase I/II trial.

被引：0
|
作者：
Sanchez, J. M.
Mellemgaard, A.
Perry, M.
Zatloukal, P.
Hamm, J.
Belani, C. P.
Kim, E.
Felip, E.
Berton, M.
Johri, A.
机构：
[1] Hosp Germans Trias & Pujol, Barcelona, Spain
[2] Herlev Hosp, DK-2730 Herlev, Denmark
[3] Ellis Fischel Canc Ctr, Columbia, MO USA
[4] Univ Hosp Na Bulovce, Prague, Czech Republic
[5] Norton Healthcare Hosp Inc, Louisville, KY USA
[6] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
[7] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Vall Hebron Univ Hosp, Barcelona, Spain
[9] Novartis Pharma AG, Basel, Switzerland
[10] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：390S / 390S
页数：1
相关论文
共 50 条
  • [1] Phase I/II trial of patupilone once every 3 weeks in patients with non-small cell lung cancer (NSCLC)
    Osterlind, K
    Sánchez, J
    Zatloukai, P
    Hamm, J
    Belani, C
    Kim, E
    Felip, E
    Sklenar, I
    Berton, M
    Johri, A
    [J]. LUNG CANCER, 2005, 49 : S261 - S261
  • [2] Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial.
    Socinski, M. A.
    Novello, S.
    Sanchez, J. M.
    Brahmer, J. A.
    Govindan, R.
    Belani, C. P.
    Atkins, J. N.
    Gillenwater, H. H.
    Palleres, C.
    Chao, R. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 364S - 364S
  • [3] ACTIVITY OF PATUPILONE IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY
    Zatloukal, P.
    Mellemgaard, A.
    Sanchez, J. M.
    Perry, M. C.
    Hamm, J. T.
    Van Meerbeeck, J.
    DeLeo, J. J.
    Gao, B.
    Johri, A. R.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [4] Efficacy and safety of sunitinib in a multicenter phase II trial of previously treated, advanced non-small cell lung cancer (NSCLC)
    Socinski, Mark A.
    Novello, Silvia
    Sanchez, Jose M.
    Brahmer, Julie
    Govindan, Ramaswamy
    Belani, Chandra P.
    Atkins, James N.
    Gillenwater, Heidi H.
    Palleres, C.
    Chao, Richard C.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 218 - 218
  • [5] Phase II trial of imatinib (I) and docetaxel (D) in recurrent non-small cell lung cancer (NSCLC)
    Huang, C. H.
    Williamson, S.
    Van Veldhuizen, P. J.
    Hsueh, C. T.
    Smith, H.
    Mayo, M.
    Allen, A.
    Kelly, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Phase I/II dose-escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer
    Sanchez, J. M.
    Osterlind, K.
    Zatloukal, P.
    Hamm, J.
    Belani, C. P.
    Kim, E.
    Felip, E.
    Berton, M.
    Sklenar, I.
    John, A.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 327 - 327
  • [7] Phase I/II dose escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer.
    Osterlind, K
    Sánchez, JM
    Zatloukal, P
    Hamm, J
    Belani, CP
    Kim, E
    Felip, E
    Johri, A
    Berton, M
    Sklenar, I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 647S - 647S
  • [8] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC).
    Lynch, TJ
    Lilenbaum, R
    Bonomi, P
    Ansari, R
    Govindan, R
    Janne, PA
    Hanna, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 637S - 637S
  • [9] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)
    Hanna, N
    Bonomi, P
    Lynch, T
    Ansari, R
    Govindan, R
    Janne, R
    Lilenbaum, R
    [J]. LUNG CANCER, 2005, 49 : S38 - S38
  • [10] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
12345